2/3
12:51 pm
rvmd
MSD's 2026 sales forecast falls short amid patent losses despite strong Q4 [Yahoo! Finance]
Low
Report
MSD's 2026 sales forecast falls short amid patent losses despite strong Q4 [Yahoo! Finance]
2/2
01:32 pm
rvmd
Revolution Medicines (NASDAQ:RVMD) had its price target raised by analysts at JPMorgan Chase & Co. from $92.00 to $122.00. They now have an "overweight" rating on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its price target raised by analysts at JPMorgan Chase & Co. from $92.00 to $122.00. They now have an "overweight" rating on the stock.
1/29
08:00 am
rvmd
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor
Low
Report
Revolution Medicines Doses First Patient in Clinical Trial Evaluating RMC-5127, a RAS(ON) G12V-Selective Inhibitor
1/28
07:02 pm
rvmd
Merck Ends Revolution Medicines Talks As Oncology Plans And Valuation Weighed [Yahoo! Finance]
Low
Report
Merck Ends Revolution Medicines Talks As Oncology Plans And Valuation Weighed [Yahoo! Finance]
1/27
08:08 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
1/27
05:31 am
rvmd
Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board [Yahoo! Finance]
Low
Report
Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board [Yahoo! Finance]
1/27
05:17 am
rvmd
Revolution Medicines (RVMD) Dives 16.9% as Merck Withdraws Takeover Plan [Yahoo! Finance]
Low
Report
Revolution Medicines (RVMD) Dives 16.9% as Merck Withdraws Takeover Plan [Yahoo! Finance]
1/26
12:38 pm
rvmd
Merck Walks Away: What The Failed Acquisition Means For Revolution Medicines [Seeking Alpha]
Low
Report
Merck Walks Away: What The Failed Acquisition Means For Revolution Medicines [Seeking Alpha]
1/26
07:36 am
rvmd
S&P 500 Futures Decline in Premarket Trading; Revolution Medicines, UFP Industries Lag [Barron's]
Medium
Report
S&P 500 Futures Decline in Premarket Trading; Revolution Medicines, UFP Industries Lag [Barron's]
1/25
08:33 pm
rvmd
Is It Too Late To Consider Revolution Medicines (RVMD) After Its 187% One-Year Surge? [Yahoo! Finance]
High
Report
Is It Too Late To Consider Revolution Medicines (RVMD) After Its 187% One-Year Surge? [Yahoo! Finance]
1/25
03:43 pm
rvmd
Merck no longer in talks to buy Revolution Medicines, WSJ reports [Yahoo! Finance]
High
Report
Merck no longer in talks to buy Revolution Medicines, WSJ reports [Yahoo! Finance]
1/25
02:59 pm
rvmd
Merck is said to halt acquisition talks with cancer drug developer Revolution [Seeking Alpha]
High
Report
Merck is said to halt acquisition talks with cancer drug developer Revolution [Seeking Alpha]
1/23
04:48 pm
rvmd
Jim Cramer Highlights “Takeover Interest” in Revolution Medicines [Yahoo! Finance]
High
Report
Jim Cramer Highlights “Takeover Interest” in Revolution Medicines [Yahoo! Finance]
1/22
10:02 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was given a new $170.00 price target on by analysts at UBS Group AG.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was given a new $170.00 price target on by analysts at UBS Group AG.
1/22
09:04 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its price target raised by analysts at Stifel Nicolaus from $85.00 to $170.00. They now have a "buy" rating on the stock.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its price target raised by analysts at Stifel Nicolaus from $85.00 to $170.00. They now have a "buy" rating on the stock.
1/21
07:17 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/20
08:11 am
rvmd
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Revolution Medicines (NASDAQ:RVMD) had its "buy" rating reaffirmed by analysts at Guggenheim.
1/19
07:40 pm
rvmd
Janus Henderson Enterprise Fund Q4 2025 Portfolio Review [Seeking Alpha]
Low
Report
Janus Henderson Enterprise Fund Q4 2025 Portfolio Review [Seeking Alpha]
1/19
07:26 pm
rvmd
Janus Henderson Enterprise Fund Q4 2025 Commentary [Seeking Alpha]
Medium
Report
Janus Henderson Enterprise Fund Q4 2025 Commentary [Seeking Alpha]
1/16
06:50 am
rvmd
On biotech's biggest stage, renewed excitement gets a stress test [Yahoo! Finance]
Low
Report
On biotech's biggest stage, renewed excitement gets a stress test [Yahoo! Finance]
1/13
09:09 am
rvmd
Revolution Medicines (NASDAQ:RVMD) was given a new $143.00 price target on by analysts at Mizuho.
Low
Report
Revolution Medicines (NASDAQ:RVMD) was given a new $143.00 price target on by analysts at Mizuho.
1/13
06:06 am
rvmd
JPM 26: Day 1 – drug prices and policy changes drive the agenda [Yahoo! Finance]
Low
Report
JPM 26: Day 1 – drug prices and policy changes drive the agenda [Yahoo! Finance]
1/12
02:38 pm
rvmd
Revolution Medicines declines to comment on M&A speculation at conference [Seeking Alpha]
Low
Report
Revolution Medicines declines to comment on M&A speculation at conference [Seeking Alpha]
1/12
11:25 am
rvmd
JPM26: Eli Lilly reportedly eyes €15bn takeover of Abivax [Yahoo! Finance]
Low
Report
JPM26: Eli Lilly reportedly eyes €15bn takeover of Abivax [Yahoo! Finance]
1/12
10:32 am
rvmd
AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense [Yahoo! Finance]
Low
Report
AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense [Yahoo! Finance]